Objective to investigate the role of IL 4 receptor (IL 4r) in allergic asthma.
目的了解白细胞介素4受体(IL 4r)在过敏性哮喘中的作用。
AIM to observe the distribution of interleukin 8 receptor (IL 8r) immunoreactivity in rat digestive tract.
目的观察白介素-8受体(IL - 8r)免疫阳性物质在大鼠消化道的存在和分布。
Duerr and colleagues (2006) have reported that the same variant in the IL-23 receptor is associated with IBD.
Duerr及其同事(2006)已报道了IBD相关遗传多态性，同样白介素- 23受体的突变。
Methods: Monoclonal and poly - clonal dual antibody sandwich method was used to assay the levels of serum interleukin - 2 (IL - 2) and soluble interleukin - 2 receptor (SIL - 2r).
方法：采用单克隆与多克隆双抗体夹心法测定血清白介素-2 (IL - 2)及可溶性白介素- 2受体(SIL - 2r)水平。
Objective to investigate the actions of protease-activated receptor 1 (PAR1) agonists and thrombin on the secretion of interleukin-8 (IL-8) from human lung epithelial cells.
目的探讨蛋白酶激活受体1 (PAR1)激动肽和凝血酶对人肺上皮细胞白细胞介素- 8 (IL - 8)分泌的影响。
Objective to study the relationship between lymph node metastasis and the expression of interleukin-6 (IL-6), interleukin-6 receptor (IL-6R) in breast cancerous tissues.
目的研究乳腺癌淋巴结转移与活体癌组织中白细胞介素6 (IL 6)及白细胞介素6受体(IL 6r)表达的关系。
The magnitude and duration of T-cell immune response are critically regulated by the interaction of interleukin-2 (IL-2) and its high-affinity receptor (IL-2R) on the surface of the cell.
白细胞介素2 (IL - 2)与其高亲和力受体(IL - 2r)的相互作用在调节T细胞免疫反应的强度和持续时间方面起着关键作用。
AIM: to determine the effect of interleukin-1 receptor antagonist (IL-lra) on allergic rhinitis.
目的：明确白介素- 1受体拮抗剂对变应性鼻炎的治疗作用。
To clone mouse interleukin 4 (mIL-4) truncated gene, construct its eukaryotic expression plasmid pFB-mIL4 and express the truncated protein (murine IL-4 receptor antagonist).
构建小鼠il -4截短型基因真核表达质粒，表达小鼠il - 4受体拮抗体蛋白。
OBJECTIVE: To observe the effect of the receptor antagonist of the IL-6 on the traumatic edema of spinal cord, and explore the effect of IL-6 in the process of the edema of spinal cord.
目的：观察白细胞介素6受体拮抗剂对外伤性脊髓水肿的影响，探讨白细胞介素6在外伤性脊髓水肿中的作用。
The levels of soluble interlukin- 2 receptor (SIL-2R), tumor necrosis factor (TNF) , and interlukin- 6 (IL-6) were measured in 72 renal allograft recipients.
检测了72例肾移植患者血中可溶性白细胞介素2受体（SIL-2R）、肿瘤坏死因子（TNF）及白细胞介素6（IL-6）的水平。
The cellular edema, degeneration and the necrosis in the receptor antagonist of the IL-6 treated group was milder than that in the wound group.
白细胞介素6受体拮抗剂治疗组细胞水肿、变性、坏死较创伤组轻。
RESULTS. : Biopsy-proven glomerular disease recurrence was similar in patients induced with alemtuzumab or IL-2 receptor antagonists.
结果：在用阿仑单抗治疗或白细胞介素-2受体拮抗剂治疗患者中的活组织检查出肾小球疾病复发率相似。
AIM to confirm R2 cells being reliable cell model to screen small molecular human interleukin-6 (IL-6) receptor antagonists.
目的确定可靠的筛选小分子人白介素6 (IL 6)受体拮抗剂先导化合物的细胞模型。
AIM to confirm R2 cells being reliable cell model to screen small molecular human interleukin-6 (IL-6) receptor antagonists.
目的确定可靠的筛选小分子人白介素6 (IL 6)受体拮抗剂先导化合物的细胞模型。
应用推荐